About Accelalox

About company

Accelalox Inc. is a privately held company developing therapies to treat musculoskeletal conditions. Our initial development program is focused on an oral, small-molecule therapy to significantly accelerate and enhance bone healing. This therapy will be used for bone fractures and spinal fusions to improve patient outcomes through accelerated healing and reduced complications.